Clinical Trial Update: Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sorafenib in combination with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Neoplasm, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-26